5-Alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial.

about

Association between age-related reductions in testosterone and risk of prostate cancer-An analysis of patients' data with prostatic diseases.The Modulating Effects of Benign Prostate Enlargement Medications on Upgrading Predictors in Patients with Gleason 6 at Biopsy.

P2860

Q38683022-5C212616-4F49-4381-B6F6-BB2B38320AEE Q41126233-54F1DB67-F237-4132-932F-B7A3C3D10F89

P2860

5-Alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial.

Item

http://www.wikidata.org/entity/Q40954634

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

5-Alpha reductase inhibitor us ...... ostate Cancer Screening Trial.

@en

type

Item

label

5-Alpha reductase inhibitor us ...... ostate Cancer Screening Trial.

@en

prefLabel

5-Alpha reductase inhibitor us ...... ostate Cancer Screening Trial.

@en

P1476

5-Alpha reductase inhibitor us ...... ostate Cancer Screening Trial.

@en

P2093

Elina K Karppa

http://www.w3.org/2001/XMLSchema#string

Kirsi Talala

http://www.w3.org/2001/XMLSchema#string

Teemu J Murtola

http://www.w3.org/2001/XMLSchema#string

Teuvo L J Tammela

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin and the risk of cancer: time-related biases in observational studies

5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer

Long-term survival of participants in the prostate cancer prevention trial.

The influence of finasteride on the development of prostate cancer.

Drug Insight: 5alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia.

Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial.

Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention

5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer.

Treatment with finasteride and prostate cancer survival.

Prostate cancer mortality in the Finnish randomized screening trial.

P304

2820-2828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.30017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

Kimmo Taari

Anssi Auvinen

P577

2016-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26804670

http://www.w3.org/2001/XMLSchema#string

P921

Finland

5-Alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial.

about

P2860

P2860

5-Alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921